Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierrick Bourgeat

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Neuroimage|August 18, 2023
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studiesAriane Bollack, Pawel J Markiewicz, Alle Meije Wink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2026
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypesTenielle Porter, Ayeisha Milligan Armstrong, Eleanor K O'Brien, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChristopher C Rowe, Azadeh Feizpour, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Neuroimage|August 18, 2023
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studiesAriane Bollack, Pawel J Markiewicz, Alle Meije Wink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2026
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypesTenielle Porter, Ayeisha Milligan Armstrong, Eleanor K O'Brien, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChristopher C Rowe, Azadeh Feizpour, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Pageof 16